# STAVUDINE; LAMIVUDINE; EFAVIRENZ
> **NDA022097** · New Drug Application · Sponsor: STRIDES ACROLAB · Approved 2007-06-01
## Drug
- **FDA Application Number:** NDA022097
- **Application type:** New Drug Application
- **Brand name:** STAVUDINE; LAMIVUDINE; EFAVIRENZ
- **Generic name:** Stavudine
- **Active ingredients:** STAVUDINE; LAMIVUDINE; EFAVIRENZ
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** STRIDES ACROLAB
- **First approval:** 2007-06-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022097)
---
*AI Analytics · CC0 1.0*